Literature DB >> 9690519

Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo.

S Battista1, F de Nigris, M Fedele, G Chiappetta, S Scala, D Vallone, G M Pierantoni, T Mega, M Santoro, G Viglietto, P Verde, A Fusco, T Megar.   

Abstract

We have recently reported that neoplastic transformation of two rat thyroid epithelial cell lines by retroviruses carrying the v-mos and v-ras Ki oncogenes is associated with a drastic increase of AP-1 activity. The most important effects were represented by the dramatic junB and fra-1 gene induction, which was abolished by the block of the transformation-induced HMGI-C protein synthesis. Here, we have further characterized the transformation-dependent AP-1 activity, by analysing the expression of different jun- and fos-related components, in rat thyroid cell lines transformed by several oncogenes, in human thyroid carcinoma cell lines, and in naturally occurring human thyroid tumours. A significant increase of Fra-1 and JunB protein levels was detected in all oncogene transformed rat thyroid cell lines. Fra-1 gene induction was demonstrated to occur also in human thyroid carcinoma cell lines and tissues. Conversely, c-Jun and JunD proteins, rather than JunB, accumulated in human thyroid carcinoma cell lines. An induction of AP-1 target genes was also detected both in rat and human thyroid transformed cell lines. Therefore, in vivo and in vitro thyroid cell transformation is associated with important compositional changes in the AP-1 complex and an increased transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690519     DOI: 10.1038/sj.onc.1201953

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

Review 1.  Expression and function of FRA1 protein in tumors.

Authors:  Xiaoyan Jiang; Hui Xie; Yingyu Dou; Jing Yuan; Da Zeng; Songshu Xiao
Journal:  Mol Biol Rep       Date:  2019-10-14       Impact factor: 2.316

2.  Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB.

Authors:  Kyung Hee Lee; Eun Young Choi; Sung Ae Koh; Min Kyoung Kim; Kyeong Ok Kim; Si Hyung Lee; Byung Ik Jang; Se Won Kim; Sang Woon Kim; Sun Kyo Song; Joon Hyuk Choi; Jae-Ryong Kim
Journal:  Exp Mol Med       Date:  2011-09-30       Impact factor: 8.718

Review 3.  Molecular pathobiology of thyroid neoplasms.

Authors:  Giovanni Tallini
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

4.  Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias.

Authors:  S Scala; G Portella; M Fedele; G Chiappetta; A Fusco
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

5.  Regulation of HGF-mediated cell proliferation and invasion through NF-κB, JunB, and MMP-9 cascades in stomach cancer cells.

Authors:  Kyung Hee Lee; Jae-Ryong Kim
Journal:  Clin Exp Metastasis       Date:  2012-01-18       Impact factor: 5.150

6.  A dominant-negative c-jun mutant inhibits lung carcinogenesis in mice.

Authors:  Jay W Tichelaar; Ying Yan; Qing Tan; Yian Wang; Richard D Estensen; Matthew R Young; Nancy H Colburn; Hulian Yin; Colleen Goodin; Marshall W Anderson; Ming You
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-17

7.  Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells.

Authors:  G Baldassarre; B Belletti; P Bruni; A Boccia; F Trapasso; F Pentimalli; M V Barone; G Chiappetta; M T Vento; S Spiezia; A Fusco; G Viglietto
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

8.  Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorectal cancer.

Authors:  Meng-Lin Huang; Chou-Chan Chen; Li-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2009-07-17       Impact factor: 2.571

9.  Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization.

Authors:  Laura Casalino; Dario De Cesare; Pasquale Verde
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

10.  Reverse engineering a hierarchical regulatory network downstream of oncogenic KRAS.

Authors:  Iwona Stelniec-Klotz; Stefan Legewie; Oleg Tchernitsa; Franziska Witzel; Bertram Klinger; Christine Sers; Hanspeter Herzel; Nils Blüthgen; Reinhold Schäfer
Journal:  Mol Syst Biol       Date:  2012       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.